Studies have demonstrated that liquiritigenin inhibits the migration of human lung adenocarcinoma A549 cells by downregulating proMMP-2 expression and suppressing the activation of the PI3K/Akt signaling pathway (Wang et al., 2012b). This evidence concerns the gene AKT1 and lung adenocarcinoma.